Senmiao Technology Ltd — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Senmiao Technology Ltd filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.39M | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $4.32M | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $8.08M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | $11.74M | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | $6.17M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $15.77M | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $2.92M | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | $494.9K | Jul 5, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.34M | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $4.29M | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $7.74M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | $4.91M | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | $2.19M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $15.66M | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $2.55M | Jul 9, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $849.8K | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $924.7K | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $1.49M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | ($2.09M) | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | $204.8K | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $3.38M | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $738.9K | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | $494.9K | Jul 5, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($3.73M) | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | ($3.67M) | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | ($3.11M) | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | ($536.6K) | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | ($10.36M) | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | ($8.67M) | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | ($4.55M) | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | ($9.86M) | Jul 5, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($3.87M) | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | ($4.38M) | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | ($6.14M) | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | ($11.56M) | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | ($6.01M) | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | ($5.60M) | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | ($1.04M) | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | ($9.86M) | Jul 5, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.62M | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $3.13M | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $6.14M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | $9.04M | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | $5.91M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $5.50M | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $1.78M | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | $1.52M | Jul 5, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $500.3K | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $7.2K | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $557.8K | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | ($9.16M) | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | ($3.94M) | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | ($6.45M) | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | ($6.26M) | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | ($775.3K) | Jul 5, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.6K | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $671.7K | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $1.15M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | $3.22M | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | $2.29M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $495.2K | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $1.4K | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | $3.0K | Jul 5, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.80M | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $9.86M | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $14.24M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | $19.88M | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | $22.30M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $15.63M | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $12.31M | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | $14.37M | Jul 5, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $5.22M | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $5.57M | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $5.74M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | $6.49M | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | $19.73M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $14.16M | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $3.93M | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | $1.50M | Jul 5, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($2.86M) | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $894.9K | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $4.39M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | $8.09M | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | $5.86M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $2.80M | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $8.38M | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | $12.88M | Jul 5, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Mar 31, 2022 | $0 | Jul 15, 2022 |
| FY2022 | Mar 31, 2021 | $135.4K | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $0 | Jul 8, 2021 |
| FY2019 | Mar 31, 2019 | $0 | Jul 5, 2019 |
| FY2019 | Mar 31, 2018 | $0 | Jul 5, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($45.11M) | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | ($41.38M) | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | ($37.72M) | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | ($34.60M) | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | ($34.06M) | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | ($23.70M) | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | ($15.03M) | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | ($10.48M) | Jul 5, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $833.6K | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | $737.7K | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | $1.61M | Jun 27, 2024 |
| FY2024 | Mar 31, 2022 | $1.19M | Jun 27, 2024 |
| FY2022 | Mar 31, 2021 | $4.34M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | $833.9K | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | $5.02M | Jul 9, 2020 |
| FY2020 | Mar 31, 2018 | $11.14M | Jul 9, 2020 |
| FY2019 | Mar 31, 2017 | $161.3K | Jul 5, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jul 10, 2025 |
| FY2023 | Mar 31, 2023 | 0 | Jul 13, 2023 |
| FY2023 | Mar 31, 2022 | 0 | Jul 13, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jul 13, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 10.52M | Jul 10, 2025 |
| FY2025 | Mar 31, 2024 | 10.52M | Jul 10, 2025 |
| FY2024 | Mar 31, 2023 | 7.74M | Jun 27, 2024 |
| FY2023 | Mar 31, 2022 | 6.19M | Jul 13, 2023 |
| FY2022 | Mar 31, 2021 | 4.98M | Jul 15, 2022 |
| FY2021 | Mar 31, 2020 | 29.01M | Jul 8, 2021 |
| FY2020 | Mar 31, 2019 | 25.95M | Jul 9, 2020 |
| FY2019 | Mar 31, 2018 | 25.88M | Jul 5, 2019 |